Skip to main content

Table 3 Clinical outcomes

From: Safety and efficacy of biocompatible perfusion strategy in a contemporary series of patients undergoing coronary artery bypass grafting – a two-center study

Outcome

Observed rate (n = 964)

STS expected rate* n = 964)

30-day mortality

14 (1.4%)

2.0%

Reoperation for bleeding

41 (4.2%)

6.0%

Postoperative stroke

9 (0.9%)

1.0%

Postoperative sternal infection

18 (1.9%)

0.5%

Postoperative renal failure

71 (7.4%)

3.0%

Postoperative MI

13 (1.3%)

 

Postoperative atrial fibrillation

241 (25%)

 

Time on the respirator (hours)

14 ± 29 (8, 2–432)

 

ICU length of stay (hours)

74 ± 73 (48, 0–1008)

 

Hospital length of stay (days)

8 ± 7 (10, 2–142)

 
  1. *Predicted outcome rate based on the American Society of Thoracic Surgeons Database risk-assessment algorithms [13].